article placeholder

NeuroTheryX Partners with Cyclica to Launch NineteenGale Therapeutics to Advance First-In-Class Cannabinoid-Inspired Drugs for Neuropsychiatric Disorders

Belinda Messick

TORONTO–(BUSINESS WIRE)– #artificialintelligence–NeuroTheryX Partners with Cyclica to Launch NineteenGale Therapeutics to Advance Cannabinoid-Inspired Drugs for Neuropsychiatric Disorders.

READ MORE: https://www.businesswire.com/news/home/20200319005388/en/NeuroTheryX-Partners-Cyclica-Launch-NineteenGale-Therapeutics-Advance/?feedref=JjAwJuNHiystnCoBq_hl-W8j9Oi60kFTomUxRDB8jhB8bDel5XZmwWFQYQPHxx__rCOi9QzgjCezTS3Nw_X6kJUrpSBm-Hav1w-UkdSlG3kCXJZE-1b1nXn968wYfofVLkaZDLiczsahzEklD3R10Q==